Abstract:Background: Drug-induced liver injury (DILI) is a leading cause of drug development failures during clinical trials and post-market introduction. Current biomarkers, such as ALT and AST, lack the necessary specificity and sensitivity needed for accurate detection. Exosomes, which protect LncRNAs from RNase degradation, could provide reliable and easily accessible options for biomarkers. Materials and methods: RNA-sequencing was used to identify differentially expressed LncRNAs (DE-LncRNAs), followed by isolation of LncRNAs from plasma exosomes in this study. Exosome characterization was conducted by transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), and Western blot (WB). Bioinformatics analysis included functional enrichment and co-expression network analysis. Five rat models were established, and quantitative real-time PCR was used to verify the specificity and sensitivity of two candidate exosomal LncRNAs. Results: The APAP-induced hepatocellular injury model was successfully established for RNA-sequencing, leading to the identification of several differentially expressed exosomal LncRNAs. Eight upregulated exosomal DE-LncRNAs were selected for validation. Among them, NONRATT018001.2 (p < 0.05) and MSTRG.73954.4 (p < 0.05) exhibited a more than 2-fold increase in expression levels. In hepatocellular injury and intrahepatic cholestasis models, both NONRATT018001.2 and MSTRG.73954.4 showed earlier increases compared to serum biomarkers ALT and AST. However, no histological changes were observed until the final time point. In the fatty liver model, NONRATT018001.2 and MSTRG.73954.4 increased earlier than ALT and AST at 21 days. By the 7th day, minor steatosis was evident in liver tissue, while the expression levels of the two candidate exosomal LncRNAs exceeded 2 and 4 times, respectively. In the hepatic fibrosis model, NONRATT018001.2 and MSTRG.73954.4 showed increases at every time point. By the 49th day, hepatocellular necrosis and fibrosis were observed in the liver tissue, with NONRATT018001.2 showing an increase of more than 8 times. The specificity of the identified exosomal DE-LncRNAs was verified using a myocardial injury model and they showed no significant differences between the case and control groups. Conclusion: NONRATT018001.2 and MSTRG.73954.4 hold potential as biomarkers for distinguishing different types of organ injury induced by drugs, particularly enabling early prediction of liver injury. Further experiments, such as siRNA interference or gene knockout, are warranted to explore the underlying mechanisms of these LncRNAs.

Aberrant Expression of SNHG12 Contributes to N, N-dimethylformamide-induced Hepatic Apoptosis Both in Short-Term and Long-Term DMF Exposure

Aberrant expression of miRNA‐192‐5p contributes to N , N ‐dimethylformamide‐induced hepatic apoptosis

Aberrant Hepatic Microrna Expression in Nonalcoholic Fatty Liver Disease

A Novel Identified Circular RNA, mmu_mmu_circRNA_0000309, Involves in Germacrone-Mediated Improvement of Diabetic Nephropathy Through Regulating Ferroptosis by Targeting miR-188-3p/GPX4 Signaling Axis

Hsa_circ_0005915 Promotes N,N-Dimethylformamide-Induced Oxidative Stress In Hl-7702 Cells Through Nrf2/Are Axis

LncRNA-241 Inhibits 1,2-Dichloroethane-induced Hepatic Apoptosis

NLRP3 inflammasome activation triggers severe inflammatory liver injury in N, N -dimethylformamide-exposed mice

Blocking SNHG14 Antagonizes Lipopolysaccharides-Induced Acute Lung Injury Via SNHG14/miR-124-3p Axis.

Allyl Methyl Disulfide (AMDS) Prevents N,N-dimethyl Formamide-Induced Liver Damage by Suppressing Oxidative Stress and NLRP3 Inflammasome Activation.

Aberrant Expression of Mir-451A Contributes to 1,2-Dichloroethane-induced Hepatic Glycerol Gluconeogenesis Disorder by Inhibiting Glycerol Kinase Expression in NIH Swiss Mice.

N,N-dimethylformamide-induced acute liver damage is driven by the activation of NLRP3 inflammasome in liver macrophages of mice

Retinoid X receptor (RXR)-mediated erythroid-2-related factor-2 (NRF2) inactivation contributes to <i>N</i>,<i>N</i>-dimethylformamide (DMF)-induced oxidative stress in HL-7702 and HuH6 cells

Long Noncoding RNA Gm20319, Acting As Competing Endogenous RNA, Regulated GNE Expression by Sponging Mir-7240-5p to Involve in Deoxynivalenol-Induced Liver Damage in Vitro.

The role of exosomal lncRNAs in acetaminophen-induced induced liver injury in SD rats

DMF-Induced Apoptosis in Human Hepatic Cells Detected by Methods of AO/EB Doubly Staining and Flow Cytometer

SNHG14 Upregulation Was a Molecular Mechanism Underlying MPP+ Neurotoxicity in Dopaminergic SK-N-SH Cells via SNHG14-miR-519a-3p-ATG10 ceRNA Pathway

Biphasic effects of ethanol consumption on N,N-dimethylformamide-induced liver injury in mice

LINC01232 targeting miR-1250-3p/MSH2 axis attenuates mesangial cell proliferation and fibrosis in diabetic nephropathy

Lncrna SNHG12 Inhibition Based on Microsystem Cell Imaging Technology Protects the Endothelium from LPS-Induced Inflammation by Inhibiting the Expression of Mir-140-3p Target Gene Fndc5

Analysis of long non-coding RNA profiled following MC-LR-induced hepatotoxicity using high-throughput sequencing.

Downregulation of long noncoding RNA CRNDE suppresses drug resistance of liver cancer cells by increasing microRNA-33a expression and decreasing HMGA2 expression